266 results on '"Picarsic, Jennifer"'
Search Results
2. Identification of Macrophages and Dendritic Cells
3. Histiocytic Pathogenesis and Derivation
4. Non-Neoplastic Accumulation of Histiocytes
5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
6. Primary Histiocytic Disorders of the Lung
7. Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
8. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
9. Founders of Pediatric Pathology: Dr. Ron Jaffe (1943–2022) – An Appreciation.
10. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
11. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
12. BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
13. Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis
14. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation
15. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
16. Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts
17. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
18. Histiocytic disorders
19. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
20. Rosai–Dorfman Disease
21. Central Nervous System Langerhans Cell Histiocytosis
22. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders
23. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis
24. Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration
25. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
26. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
27. Childhood-onset Erdheim-Chester Disease in the molecular era: clinical phenotype and long-term outcome of 21 patients
28. Lorlatinib use in an infant with thalamic ALK‐positive histiocytosis
29. Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration
30. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
31. Contributors
32. Disorders of Histiocytes
33. Bone Marrow-Derived BRAFV600E-Mutated Cells Drive Neurodegeneration in a Mouse Model of Langerhans Cell Histiocytosis
34. Histiocytic Disorders of Childhood
35. Lineage-switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
36. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders
37. Rosai–Dorfman Disease
38. Central Nervous System Langerhans Cell Histiocytosis
39. ALK-positive histiocytosis:a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
40. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
41. A Chronic Eyelid Lesion in a child: Multi-Disciplinary Approach to Diagnosis, Treatment and Management of a Highly Atypical Histiocytic Lesion
42. Expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
43. ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition.
44. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAFV600E mutation
45. Hypoplasia of Extrahepatic Biliary Tree and Intrahepatic Cholangiolopathy in Cystic Fibrosis Imperfectly Mimic Biliary Atresia in 4 Infants With Cystic Fibrosis and Kasai Portoenterostomy
46. Lineage switching of the cellular distribution of BRAFV600Ein multisystem Langerhans cell histiocytosis
47. BRAF V600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
48. A chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion
49. Three decades of progress from surgery to medical therapy for isolated neuroaxis BRAF V600E–positive Langerhans cell histiocytosis management: illustrative case
50. BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.